abstract |
The present invention relates to a novel compound of a reverse-turn analog and a method for preparing the same, having a pyrazino-triazinone as a basic structure, and also to a disease therapeutic agent such as an anti-cancer effect of the compound, especially acute myeloid leukemia. It relates to the use as a therapeutic agent. |